Corrigendum: Differential Expression Analysis Revealing CLCA1 to Be a Prognostic and Diagnostic Biomarker for Colorectal Cancer

Fang-Ze Wei,Shi-Wen Mei,Zhi-Jie Wang,Jia-Nan Chen,Hai-Yu Shen,Fu-Qiang Zhao,Juan Li,Zheng Liu,Qian Liu

DOI: https://doi.org/10.3389/fonc.2020.634122

IF: 4.7

2020-12-18

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2020.573295.].

oncology

What problem does this paper attempt to address?

Corrigendum: Label-free LC-MS/MS proteomics analyses reveal CLIC1 as a predictive biomarker for bladder cancer staging and prognosis

Weifeng Wang,Guankai Huang,Hansen Lin,Lei Ren,Liangmin Fu,Xiaopeng Mao

DOI: https://doi.org/10.3389/fonc.2023.1216134

IF: 4.7

2024-01-09

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2022.1102392.].

oncology
Corrigendum: LCN2 Is a Potential Biomarker for Radioresistance and Recurrence in Nasopharyngeal Carcinoma

Meng-Xia Zhang,Li Wang,Lei Zeng,Zi-Wei Tu

DOI: https://doi.org/10.3389/fonc.2021.670714

IF: 4.7

2021-03-18

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2020.605777.].

oncology
Corrigendum: Comprehensive transcriptomic analysis of critical RNA regulation associated with metabolism and prognosis in clear cell renal carcinoma

Si Liu,Honglan Zhou,Gang Wang,Xin Lian

DOI: https://doi.org/10.3389/fcell.2023.1216783

IF: 5.5

2023-06-01

Frontiers in Cell and Developmental Biology

Abstract:[This corrects the article DOI: 10.3389/fcell.2021.709490.].

cell biology,developmental biology
Corrigendum: Multifunctions of CRIF1 in Cancers and Mitochondrial Dysfunction.

Yangzhou Jiang,Yang Xiang,Chuanchuan Lin,Weiwei Zhang,Zhenxing Yang,Lixin Xiang,Yanni Xiao,Li Chen,Qian Ran,Zhongjun Li

DOI: https://doi.org/10.3389/fonc.2023.1271492

IF: 4.7

2023-01-01

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2022.1009948.].
Corrigendum: CORO1C is Associated with Poor Prognosis and Promotes Metastasis Through PI3K/AKT Pathway in Colorectal Cancer

Zongxia Wang,Lizhou Jia,Yushu sun,Chunli Li,Lingli Zhang,Xiangcheng Wang,Hao Chen

DOI: https://doi.org/10.3389/fmolb.2021.727347

IF: 6.113

2021-08-30

Frontiers in Molecular Biosciences

Abstract:[This corrects the article DOI: 10.3389/fmolb.2021.682594.].

biochemistry & molecular biology
Corrigendum to “ARMCX Family Gene Expression Analysis and Potential Prognostic Biomarkers for Prediction of Clinical Outcome in Patients with Gastric Carcinoma”

TingAn Wang,HuaGe Zhong,YuZhou Qin,WeiYuan Wei,Zhao Li,MingWei Huang,XiaoLing Luo

DOI: https://doi.org/10.1155/2021/3179693

2021-02-09

BioMed Research International

Abstract:[This corrects the article DOI: 10.1155/2020/3575038.].

biotechnology & applied microbiology,medicine, research & experimental
Corrigendum: A comprehensive analysis of HAVCR1 as a prognostic and diagnostic marker for pan-cancer

Sheng Liu,Wenting Tang,Jing Cao,Mei Shang,Sun Hengchang,Jiao Gong,Bo Hu

DOI: https://doi.org/10.3389/fgene.2024.1357409

IF: 3.7

2024-01-26

Frontiers in Genetics

Abstract:[This corrects the article DOI: 10.3389/fgene.2022.904114.].

genetics & heredity
Differential Expression Analysis Revealing CLCA1 to Be a Prognostic and Diagnostic Biomarker for Colorectal Cancer

Fang-Ze Wei,Shi-Wen Mei,Zhi-Jie Wang,Jia-Nan Chen,Hai-Yu Shen,Fu-Qiang Zhao,Juan Li,Zheng Liu,Qian Liu

DOI: https://doi.org/10.3389/fonc.2020.573295

IF: 4.7

2020-10-28

Frontiers in Oncology

Abstract:Colorectal cancer (CRC) is a common malignant tumor of the digestive tract and lacks specific diagnostic markers. In this study, we utilized 10 public datasets from the NCBI Gene Expression Omnibus (NCBI-GEO) database to identify a set of significantly differentially expressed genes (DEGs) between tumor and control samples and WGCNA (Weighted Gene Co-Expression Network Analysis) to construct gene co-expression networks incorporating the DEGs from The Cancer Genome Atlas (TCGA) and then identify genes shared between the GEO datasets and key modules. Then, these genes were screened via MCC to identify 20 hub genes. We utilized regression analyses to develop a prognostic model and utilized the random forest method to validate. All hub genes had good diagnostic value for CRC, but only CLCA1 was related to prognosis. Thus, we explored the potential biological value of CLCA1. The results of gene set enrichment analysis (GSEA) and immune infiltration analysis showed that CLCA1 was closely related to tumor metabolism and immune invasion of CRC. These analysis results revealed that CLCA1 may be a candidate diagnostic and prognostic biomarker for CRC.

oncology
Corrigendum: EXOSC5 As a Novel Prognostic Marker Promotes Proliferation of Colorectal Cancer Via Activating the ERK and AKT Pathways

Hongda Pan,Jingxin Pan,Shibo Song,Lei Ji,Hong Lv,Zhangru Yang

DOI: https://doi.org/10.3389/fonc.2021.670041

IF: 4.7

2021-01-01

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2019.00643.].
Corrigendum: Dissecting the single-cell transcriptome network of immune environment underlying cervical premalignant lesion, cervical cancer and metastatic lymph nodes

Chunbo Li,Keqin Hua

DOI: https://doi.org/10.3389/fimmu.2024.1386072

IF: 7.3

2024-02-23

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.897366.].

immunology
Corrigendum: Identification of DYNLT1 associated with proliferation, relapse, and metastasis in breast cancer

Sen Miao,Gaoda Ju,Chonghua Jiang,Bing Xue,Lihua Zhao,Rui Zhang,Han Diao,Xingzhou Yu,Linlin Zhang,Xiaozao Pan,Hua Zhang,Lijuan Zang,Lei Wang,Tianhao Zhou

DOI: https://doi.org/10.3389/fmed.2024.1375203

IF: 3.9

2024-02-05

Frontiers in Medicine

Abstract:[This corrects the article DOI: 10.3389/fmed.2023.1167676.].

medicine, general & internal
Corrigendum: Transmembrane and coiled-coil domains 3 is a diagnostic biomarker for predicting immune checkpoint blockade efficacy in hepatocellular carcinoma

Xinyao Hu,Hua Zhu,Shi Feng,Chaoqun Wang,Yingze Ye,Xiaoxing Xiong

DOI: https://doi.org/10.3389/fgene.2022.1117731

IF: 3.7

2023-01-16

Frontiers in Genetics

Abstract:[This corrects the article DOI: 10.3389/fgene.2022.1006357.].

genetics & heredity
Corrigendum to “PIPKIγ Regulates CCL2 Expression in Colorectal Cancer by Activating AKT-STAT3 Signaling”

JunLi Xue,XiaoXiao Ge,Wei Zhao,Liqiong Xue,Congqi Dai,Fengjuan Lin,Wei Peng

DOI: https://doi.org/10.1155/2020/1786505

IF: 4.4929

2020-09-26

Journal of Immunology Research

Abstract:[This corrects the article DOI: 10.1155/2019/3690561.].

immunology
Corrigendum: Long non-coding RNA AL139385.1 as a novel prognostic biomarker in lung adenocarcinoma

Xi Chen,Jishu Guo,Fan Zhou,Wenjun Ren,Xiaobin Huang,Jun Pu,Xiaoqun Niu,Xiulin Jiang

DOI: https://doi.org/10.3389/fonc.2024.1223478

IF: 4.7

2024-09-04

Frontiers in Oncology

Abstract:This article is a correction to: Long Non-Coding RNA AL139385.1 as a Novel Prognostic Biomarker in Lung Adenocarcinoma

oncology
Corrigendum: Correlation analysis of MRD positivity in patients with completely resected stage I-IIIA non-small cell lung cancer: a cohort study

Daling Dong,Shixin Zhang,Bin Jiang,Wei Wei,Chao Wang,Qian Yang,Tingzhi Yan,Min Chen,Liken Zheng,Weikang Shao,Gang Xiong

DOI: https://doi.org/10.3389/fonc.2023.1275851

IF: 4.7

2023-08-25

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2023.1222716.].

oncology
Corrigendum: Identification of BRCA1:c.5470_5477del as a Founder Mutation in Chinese Ovarian Cancer Patients

Jun Li,Sile Han,Cuiyun Zhang,Yanlin Luo,Li Wang,Ping Wang,Yi Wang,Qingxin Xia,Xiaoyan Wang,Bing Wei,Jie Ma,Hongle Li,Yongjun Guo

DOI: https://doi.org/10.3389/fonc.2021.840551

IF: 4.7

2022-01-14

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.655709.].

oncology
Corrigendum: MXD3 as an Immunological and Prognostic Factor From Pancancer Analysis

Xiaoyu Zhang,Xiaoqin He,Yue Li,Yangtao Xu,Wenliang Chen,Xin Liu,Xinyao Hu,Lin Xiong,Ximing Xu

DOI: https://doi.org/10.3389/fmolb.2021.826905

IF: 6.113

2021-12-22

Frontiers in Molecular Biosciences

Abstract:[This corrects the article DOI: 10.3389/fmolb.2021.702206.].

biochemistry & molecular biology
Corrigendum: High expression level of the FTH1 gene is associated with poor prognosis in children with non-M3 acute myeloid leukemia

Junlin Zhang,Liying Liu,Jinshuang Wei,Xiaojing Wu,Jianming Luo,Hongying Wei,Liao Ning,Yunyan He

DOI: https://doi.org/10.3389/fonc.2023.1212991

2023-08-21

Abstract:[This corrects the article DOI: 10.3389/fonc.2022.1068094.].
Corrigendum: AFAP1-AS1 Promotes Epithelial-Mesenchymal Transition and Tumorigenesis Through Wnt/β-Catenin Signaling Pathway in Triple-Negative Breast Cancer

Kaiming Zhang,Peng Liu,Hailin Tang,Xiaoming Xie,Yanan Kong,Cailu Song,Xingsheng Qiu,Xiangsheng Xiao

DOI: https://doi.org/10.3389/fphar.2020.01107

IF: 5.6

2020-07-20

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2018.01248.].

pharmacology & pharmacy
Corrigendum: DDX5 and DDX17—multifaceted proteins in the regulation of tumorigenesis and tumor progression

Kun Xu,Shenghui Sun,Mingjing Yan,Ju Cui,Yao Yang,Wenlin Li,Xiuqing Huang,Lin Dou,Beidong Chen,Weiqing Tang,Ming Lan,Jian Li,Tao Shen

DOI: https://doi.org/10.3389/fonc.2023.1204712

IF: 4.7

2023-06-02

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2022.943032.].

oncology

Corrigendum: Differential Expression Analysis Revealing CLCA1 to Be a Prognostic and Diagnostic Biomarker for Colorectal Cancer

Corrigendum: Label-free LC-MS/MS proteomics analyses reveal CLIC1 as a predictive biomarker for bladder cancer staging and prognosis

Corrigendum: LCN2 Is a Potential Biomarker for Radioresistance and Recurrence in Nasopharyngeal Carcinoma

Corrigendum: Comprehensive transcriptomic analysis of critical RNA regulation associated with metabolism and prognosis in clear cell renal carcinoma

Corrigendum: Multifunctions of CRIF1 in Cancers and Mitochondrial Dysfunction.

Corrigendum: CORO1C is Associated with Poor Prognosis and Promotes Metastasis Through PI3K/AKT Pathway in Colorectal Cancer

Corrigendum to “ARMCX Family Gene Expression Analysis and Potential Prognostic Biomarkers for Prediction of Clinical Outcome in Patients with Gastric Carcinoma”

Corrigendum: A comprehensive analysis of HAVCR1 as a prognostic and diagnostic marker for pan-cancer

Differential Expression Analysis Revealing CLCA1 to Be a Prognostic and Diagnostic Biomarker for Colorectal Cancer

Corrigendum: EXOSC5 As a Novel Prognostic Marker Promotes Proliferation of Colorectal Cancer Via Activating the ERK and AKT Pathways

Corrigendum: Dissecting the single-cell transcriptome network of immune environment underlying cervical premalignant lesion, cervical cancer and metastatic lymph nodes

Corrigendum: Identification of DYNLT1 associated with proliferation, relapse, and metastasis in breast cancer

Corrigendum: Transmembrane and coiled-coil domains 3 is a diagnostic biomarker for predicting immune checkpoint blockade efficacy in hepatocellular carcinoma

Corrigendum to “PIPKIγ Regulates CCL2 Expression in Colorectal Cancer by Activating AKT-STAT3 Signaling”

Corrigendum: Long non-coding RNA AL139385.1 as a novel prognostic biomarker in lung adenocarcinoma

Corrigendum: Correlation analysis of MRD positivity in patients with completely resected stage I-IIIA non-small cell lung cancer: a cohort study

Corrigendum: Identification of BRCA1:c.5470_5477del as a Founder Mutation in Chinese Ovarian Cancer Patients

Corrigendum: MXD3 as an Immunological and Prognostic Factor From Pancancer Analysis

Corrigendum: High expression level of the FTH1 gene is associated with poor prognosis in children with non-M3 acute myeloid leukemia

Corrigendum: AFAP1-AS1 Promotes Epithelial-Mesenchymal Transition and Tumorigenesis Through Wnt/β-Catenin Signaling Pathway in Triple-Negative Breast Cancer

Corrigendum: DDX5 and DDX17—multifaceted proteins in the regulation of tumorigenesis and tumor progression